BioNexus Gene Lab Corp
BGLCNasdaqCIK 1737523HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0713:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-006075 |
| 2026-08-1421:29 ET | SCHEDULE 13D | Ownership report, active investor | 0001520138-26-000354 |
| 2026-08-1421:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001477932-26-005093 |
| 2026-07-2818:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004556 |
| 2026-06-0513:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-003658 |
| 2026-05-1521:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001477932-26-003242 |
| 2026-04-1421:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001477932-26-002218 |
| 2026-03-1718:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-001379 |
| 2026-02-2313:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000964 |
| 2026-02-0321:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000610 |
| 2025-12-3018:30 ET | 8-K | 5.07 Shareholder vote results | 0001477932-25-009240 |
| 2025-12-2322:20 ET | 8-K | 8.01 Other events | 0001477932-25-009186 |
| 2025-12-0322:15 ET | DEF 14A | Proxy statementPeriod 2025-12-24 | 0001477932-25-008757 |
| 2025-12-0213:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008724 |
| 2025-11-1422:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001477932-25-008343 |
| 2025-11-1313:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008137 |
| 2025-11-1213:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008044 |
| 2025-10-2312:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-007708 |
| 2025-08-1820:48 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001477932-25-006023 |
| 2025-07-3014:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-005322 |
| 2025-06-2319:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-004754 |
| 2025-05-1520:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001477932-25-003821 |
| 2025-04-3015:16 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-003114 |
| 2025-04-2919:22 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001477932-25-003062 |
| 2025-04-1515:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001477932-25-002725 |
| 2025-04-1015:50 ET | 8-K | 3.03 Change to security holders’ rights | 0001477932-25-002574 |
| 2025-04-0313:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-25-002406 |
| 2025-03-2517:15 ET | 8-K | 5.07 Shareholder vote results | 0001477932-25-001958 |
| 2025-03-0716:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-001531 |
| 2025-03-0516:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-001484 |
| 2025-02-2722:20 ET | DEF 14A | Proxy statementPeriod 2025-03-19 | 0001477932-25-001335 |
| 2025-02-1422:20 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-25-001063 |
| 2025-01-0215:30 ET | 8-K | 3.01 Delisting notice | 0001477932-25-000006 |
| 2024-11-1522:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001477932-24-007332 |
| 2024-11-0822:25 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001477932-24-006996 |
| 2024-10-1521:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-24-006440 |
| 2024-10-1021:29 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001477932-24-006352 |
| 2024-09-2515:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-005924 |
| 2024-09-1818:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005817 |
| 2024-09-1621:20 ET | DEF 14A | Proxy statementPeriod 2024-10-04 | 0001477932-24-005760 |
| 2024-09-1219:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005680 |
| 2024-09-0517:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-24-005537 |
| 2024-08-2814:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005339 |
| 2024-08-2616:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-005269 |
| 2024-08-1418:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001477932-24-004792 |
| 2024-07-0521:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-24-004096 |
| 2024-05-3119:47 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001477932-24-003422 |
| 2024-05-3119:46 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-09-30 | 0001477932-24-003421 |
| 2024-05-3119:46 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001477932-24-003420 |
| 2024-05-3119:45 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001477932-24-003419 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.